ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy: Feasibility Study (CARTePRO)
This study is designed as a feasibility study implementing electronic Patient Reported Outcomes (ePRO) in CAR T treatment for hematological malignancies, in order to describe AE reporting. ePRO assessments will be explored for their feasibility to engage in monitoring and management of CAR T-related toxicities as well as using these digital ePRO tools may improve both, its safety and accessibility.
Oral Medicinal Cannabis (CBD:THC) as Add-On to Standard of Care for Symptomatic and Palliative Treatment in Cancer Patients - a Multicentre Prospective Patient Registry in Switzerland and Germany. - Swiss CanOn - Swiss Cannabis Oncology
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer: A Multicenter Observational Cohort Study
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients.
100 项与 Stiftung Swiss Tumor Institute 相关的临床结果
0 项与 Stiftung Swiss Tumor Institute 相关的专利（医药）
100 项与 Stiftung Swiss Tumor Institute 相关的药物交易
100 项与 Stiftung Swiss Tumor Institute 相关的转化医学
